From the country that laid down the principal laws of heredity, introduced the contact lens to the world and successfully developed the compounds on which current anti-AIDS drugs are based, the Czech Republic is an attractive location for contract R&D and manufacturing.

Development of life-sciences sector is supported by effective patent protection, adoption of GMP, GLP and GCP standards, public support for R&D and relatively non-restrictive genetic-engineering policies. Examples of global companies conducting business, R&D and/or manufacturing in the Czech Republic include TEVA Pharmaceuticals, Lonza Biotec, Baxter International, Otsuka Pharmaceuticals, Sanofi Aventis, Beckman Coulter and Zentiva, among others.

Key Companies 2

Reasons to invest:

  • World-class academic and institutional framework with significant achievements in basic and applied research
  • Availability of university graduates and laboratory technicians at competitive cost
  • Close links between industry, universities and the public healthcare system
  • Established industrial R&D, manufacturing and supply chain
  • Regulatory and patent environment harmonious with the EU
  • Strong presence of large international pharmaceutical companies participating in research programmes
  • Significant cost advantages and potential to establish a gateway to growing markets of Central and Eastern Europe
  • Supportive business environment and incentives for both R&D and manufacturing


Should you be interested in more information please do not hesitate to contact us at

See more information about upcoming events at

Attached files

Description Type Size Date

Life Sciences in the Czech Republic

Brochure: Sector Overwiev ▪ R&D ▪ Skills & Education ▪ Company Focus ▪ Business Infrastructure ▪

1.29 MB 10 Oct. 2017